Evidence map›Paper›PMID 38390163›Full record

ArticleHeliyon2024

Four case reports of left anterior descending restenosis treated via the internal mammary artery: A literature review.

Zongke Kou, Rui Mao, Yirong Gan, Yunlong Zhang, Bing Li, Xiaoqing Kou, Jing Xie, Liying Zhang, Tianxiang Liang, Dingxiong Xie and 1 more

Abstract readCase Reports
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zongke KouGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Rui MaoGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Yirong GanGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Yunlong ZhangGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Bing LiGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Xiaoqing KouGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Jing XieDeparment of Functional Examination Section, The First people's Hospital of Lanzhou City, Lanzhou, 730050, China.
Liying ZhangGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Tianxiang LiangGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.
Dingxiong XieDeparment of Cardiovascular surgery, The First people's Hospital of Lanzhou City, Lanzhou, 730050, China.
Yanzhen WangGansu Institute of Cardiovascular Diseases, Lanzhou, 730050, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyse four cases of intervention via the internal mammary artery-anterior descending branch and provide and summarise the clinical treatment experience. Methods: The clinical data of four patients with distal restenosis of a left anterior descending artery (LAD) anastomosis after left internal mammary artery (LIMA)-LAD bypass surgery, who were admitted to the Gansu Institute of Cardiovascular Diseases between March 2013 and April 2022, were retrospectively analysed and reviewed together with the relevant literature. Results: Among the four patients, one was treated with intracoronary stenting via the internal mammary artery route, two were treated with intracoronary drug-coated balloon dilation (one of whom underwent fractional flow reserve [FFR] testing), and two underwent FFR testing (one of whom had a negative test result until the end of the procedure and continued to take medication during follow-up; the other patient had a positive result and further interventions). There were no deaths or postoperative complications in the group, and the patients were followed up for 4 months to 9 years, with good long-term outcomes. Conclusion: Percutaneous coronary intervention (PCI) via the internal mammary artery route is safe and effective, and patients with anastomotic distal stenosis or anastomotic stenosis of LAD bypass anastomosis may be considered for PCI via the internal mammary artery route.

Indexed as

Coronary artery bypass graftingCoronary interventionFractional flow reserve examinationInternal mammary artery

Identifiers

PMID38390163
PMCPMC10881538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.